The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Oxygen sensing by HIF hydroxylases
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under well-oxygenated conditions HIFα becomes hydroxylated at one (or both) of two highly conserved prolyl residues located near the NTAD by members of the prolyl hydroxylase domain (PHD) family (also called EgIN family or HPH family) (for reviews see Kaelin, 2005; Schofield and Ratcliffe, 2004).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Schofield and Ratcliffe, 2004
In the citing paper
“When oxygen is available, FIH1 hydroxylates a conserved asparaginyl residue within the HIF1α and HIF2α CTADs, leading to a steric clash that prevents the recruitment of the coactivators p300 and CBP (for reviews see Kaelin, 2005; Schofield and Ratcliffe, 2004).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Schofield and Ratcliffe, 2004
In the citing paper
“Ascorbate is required for full catalytic activity and likely functions to reduce the catalytic iron in the event of uncoupled turnover, in which failure to oxidize the HIFα substrate leaves the iron center in an oxidized and inactive form (Schofield and Ratcliffe, 2004).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Schofield and Ratcliffe, 2004
In the citing paper
“This hydroxylation is mediated by prolyl-4-hydroxylases (PHDs), a set of oxygen-, iron-, and ascorbatedependent enzymes belonging to the 2-oxoglutarate-dependent oxygenase superfamily (Schofield & Ratcliffe, 2004).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Schofield & Ratcliffe, 2004
In the citing paper
“From a mechanistic standpoint, HIF activation drives tumor progression by coordinating transcriptional programs that promote glycolytic metabolism, angiogenic factor production, cell survival, proliferation, immune evasion, and maintenance of cancer stem like properties [20,250,251].”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [250]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Self-citationThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Self-citationHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Self-citationSemenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Self-citationMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 1×
“For example, defects in the genes that encode the succinate dehydrogenase subunits B, C and”
BackgroundThe Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558
Lando, D., Peet, D. J., Gorman, J. J., Whelan, D. A., Whitelaw, M. L., & Bruick, R. K. (2002) · Genes & Development · doi:10.1101/gad.991402 · Cited by 1,550 · cited 1×
“Like prolyl hydroxylation, HIF asparaginyl hydroxylation is also catalysed by a member of the 2-oxoglutarate-dependent-oxygenase superfamily, but one that is significantly different in sequence to the PHD”
BackgroundMahon, P. C., Hirota, K., & Semenza, G. L. (2001) · Genes & Development · doi:10.1101/gad.924501 · Cited by 1,385
Berra, E., Benizri, E., Ginouvès, A., Volmat, V., Roux, D., & Pouysségur, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg392 · Cited by 1,348
Jiang, B. H., Semenza, G. L., Bauer, C., & Marti, H. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.4.c1172 · Cited by 1,213
Wenger, R. H. (2002) · The FASEB Journal · doi:10.1096/fj.01-0944rev · Cited by 1,135
Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5197 · Cited by 1,014
Self-citationHypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology
Semenza, G. L. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02090-1 · Cited by 930
Crystallographic and Spectroscopic Characterization of a Nonheme Fe(IV)=O Complex
Rohde, J.-U., In, J.-H., Lim, M. H., Brennessel, W. W., Bukowski, M. R., Stubna, A., Münck, E., Nam, W., & Que, L. (2003) · Science · doi:10.1126/science.299.5609.1037 · Cited by 929
HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation
Yu, F., White, S. B., Zhao, Q., & Lee, F. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181341498 · Cited by 796
Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor
Hirsilä, M., Koivunen, P., Günzler, V., Kivirikko, K. I., & Myllyharju, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304982200 · Cited by 794
Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling
Min, J.-H., Yang, H., Ivan, M., Gertler, F., Kaelin, W. G., & Pavletich, N. P. (2002) · Science · doi:10.1126/science.1073440 · Cited by 765
Carnitine biosynthesis in mammals
Vaz, F. M., & Wanders, R. J. A. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3610417 · Cited by 764
Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damage
Trewick, S. C., Henshaw, T. F., Hausinger, R. P., Lindahl, T., & Sedgwick, B. (2002) · Nature · doi:10.1038/nature00908 · Cited by 762
Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL
Hon, W.-C., Wilson, M. I., Harlos, K., Claridge, T. D. W., Schofield, C. J., Pugh, C. W., Maxwell, P. H., Ratcliffe, P. J., Stuart, D. I., & Jones, E. Y. (2002) · Nature · doi:10.1038/nature00767 · Cited by 751
Self-citationPrice, J. C., Barr, E. W., Tirupati, B., Bollinger, & Krebs, C. (2003) · Biochemistry · doi:10.1021/bi030011f · Cited by 737
Hewitson, K. S., McNeill, L. A., Riordan, M. V., Tian, Y.-M., Bullock, A. N., Welford, R. W., Elkins, J. M., Oldham, N. J., Bhattacharya, S., Gleadle, J. M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200273200 · Cited by 719
Self-citationInhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression
Makino, Y., Cao, R., Svensson, K., Bertilsson, G., Asman, M., Tanaka, H., Cao, Y., Berkenstam, A., & Poellinger, L. (2001) · Nature · doi:10.1038/35107085 · Cited by 705 · cited 1×
“This protein — known as inhibitory PAS protein (IPAS) — forms transcriptionally inactive heterodimers with HIF1α (Ref”
BackgroundRedistribution of Intracellular Oxygen in Hypoxia by Nitric Oxide: Effect on HIF1α
Hagen, T., Taylor, C. T., Lam, F., & Moncada, S. (2003) · Science · doi:10.1126/science.1088805 · Cited by 704
Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA
Aas, P. A., Otterlei, M., Falnes, P. Ø., Vågbø, C. B., Skorpen, F., Akbari, M., Sundheim, O., Bjørås, M., Slupphaug, G., Seeberg, E., et al. (2003) · Nature · doi:10.1038/nature01363 · Cited by 638
Yuan, Y., Hilliard, G., Ferguson, T., & Millhorn, D. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300463200 · Cited by 638 · cited 1×
“So, the classic hypoxia-mimetic function of cobaltous ions can probably be explained by their direct inhibition of the HIF hydroxylases, although the direct binding of cobalt to the HIFα CODDD has been reported, which might contribute to HIFα stabilit”
BackgroundAlkB-mediated oxidative demethylation reverses DNA damage in Escherichia coli
Falnes, P. Ø., Johansen, R. F., & Seeberg, E. (2002) · Nature · doi:10.1038/nature01048 · Cited by 616
Expression of Hypoxia-Inducible Factor-1α and -2α in Hypoxic and Ischemic Rat Kidneys
Rosenberger, C., Mandriota, S., Ju[Combining Diaeresis]rgensen, J. S., Wiesener, M. S., Ho[Combining Diaeresis]rstrup, J. H., Frei, U., Ratcliffe, P. J., Maxwell, P. H., Bachmann, S., & Eckardt, K.-U. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000017223.49823.2a · Cited by 567
Self-citationIvan, M., Haberberger, T., Gervasi, D. C., Michelson, K. S., Günzler, V., Kondo, K., Yang, H., Sorokina, I., Conaway, R. C., Conaway, J. W., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192342099 · Cited by 561
Aravind, L., & Koonin, E. V. (2001) · Genome Biology · doi:10.1186/gb-2001-2-3-research0007 · Cited by 539
Hegg, E. L., & Jr, L. Q. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-1-00625.x · Cited by 521
Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α
Freedman, S. J., Sun, Z.-Y. J., Poy, F., Kung, A. L., Livingston, D. M., Wagner, G., & Eck, M. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082117899 · Cited by 455
The role of iron in cell cycle progression and the proliferation of neoplastic cells
Le, N. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00068-9 · Cited by 453
Koivunen, P., Hirsilä, M., Günzler, V., Kivirikko, K. I., & Myllyharju, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312254200 · Cited by 447
Kimura, H., Weisz, A., Kurashima, Y., Hashimoto, K., Ogura, T., D'Acquisto, F., Addeo, R., Makuuchi, M., & Esumi, H. (2000) · Blood · doi:10.1182/blood.v95.1.189 · Cited by 439
Activation of the HIF pathway in cancer
Maxwell, P. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00193-3 · Cited by 426
Crystal structure of isopenicillin N synthase is the first from a new structural family of enzymes
Roach, P. L., Clifton, I. J., Fülöp, V., Harlos, K., Barton, G. J., Hajdu, J., Andersson, I., Schofield, C. J., & Baldwin, J. E. (1995) · Nature · doi:10.1038/375700a0 · Cited by 420
Self-citationNitric Oxide Impairs Normoxic Degradation of HIF-1α by Inhibition of Prolyl Hydroxylases
Metzen, E., Zhou, J., Jelkmann, W., Fandrey, J., & Brüne, B. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-12-0791 · Cited by 414
Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2423 · Cited by 411
Self-citationStructural and mechanistic studies on 2-oxoglutarate-dependent oxygenases and related enzymes
Schofield, C. J., & Zhang, Z. (1999) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)00036-6 · Cited by 408
Self-citationStructural basis for Hif-1α/CBP recognition in the cellular hypoxic response
Dames, S. A., Martinez-Yamout, M., De Guzman, R. N., Dyson, H. J., & Wright, P. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082121399 · Cited by 402
Elkins, J. M., Hewitson, K. S., McNeill, L. A., Seibel, J. F., Schlemminger, I., Pugh, C. W., Ratcliffe, P. J., & Schofield, C. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200644200 · Cited by 391
Self-citationStructure and Mechanism of Anthocyanidin Synthase from Arabidopsis thaliana
Wilmouth, R. C., Turnbull, J. J., Welford, R. W. D., Clifton, I. J., Prescott, A. G., & Schofield, C. J. (2002) · Structure · doi:10.1016/s0969-2126(01)00695-5 · Cited by 359
Self-citation(2003) · PubMed · Cited by 350
Self-citationEvolution of functional diversity in the cupin superfamily
Dunwell, J. M., Culham, A., Carter, C. E., Sosa-Aguirre, C. R., & Goodenough, P. W. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01981-8 · Cited by 341
Structure of a cephalosporin synthase
Valegård, K., van Scheltinga, A. C. T., Lloyd, M. D., Hara, T., Ramaswamy, S., Perrakis, A., Thompson, A., Lee, H.-J., Baldwin, J. E., Schofield, C. J., et al. (1998) · Nature · doi:10.1038/29575 · Cited by 337
Self-citationKivirikko, K. I., Myllylä, R., & Pihlajaniemi, T. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.5.2537773 · Cited by 320
Hypoxia-inducible Factor and Its Biomedical Relevance
Huang, L. E., & Bunn, H. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r200030200 · Cited by 315
Inhibition of Hypoxia-inducible Factor 1 Activation by Carbon Monoxide and Nitric Oxide
Huang, L. E., Willmore, W. G., Gu, J., Goldberg, M. A., & Bunn, H. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.9038 · Cited by 291
104 candidate genes for the hypoxic tumor phenotype
Koong, A. C., Denko, N. O., Schindler, C., Le, Q. T., Terris, D. T., Ibrahim, H. Z., Goffinet, D. R., & Giaccia, A. J. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)90122-0 · Cited by 285
Prolyl 4-hydroxylases and their protein disulfide isomerase subunit
Kivirikko, K. I., & Myllyharju, J. (1998) · Matrix Biology · doi:10.1016/s0945-053x(98)90009-9 · Cited by 285
Maynard, M. A., Qi, H., Chung, J., Lee, E. H. L., Kondo, Y., Hara, S., Conaway, R. C., Conaway, J. W., & Ohh, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208681200 · Cited by 283
Wykoff, C. C., Pugh, C. W., Maxwell, P. H., Harris, A. L., & Ratcliffe, P. J. (2000) · Oncogene · doi:10.1038/sj.onc.1204012 · Cited by 266
Self-citationRole of Prolyl Hydroxylation in Oncogenically Stabilized Hypoxia-inducible Factor-1α
Chan, D. A., Sutphin, P. D., Denko, N. C., & Giaccia, A. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206922200 · Cited by 264 · cited 1×
“Using hydroxylation-specific antibodies, it has been shown that the HIF1α CODDD is not always fully hydroxylated in such cell”
MethodStructural origins of the selectivity of the trifunctional oxygenase clavaminic acid synthase.
Harlos, K., Schofield, C. J., Zhang, Z., Ren, J., STAMMERS, D. K., & Baldwin, J. E. (2000) · Nature Structural Biology · doi:10.1038/72398 · Cited by 260
Self-citationLavista-Llanos, S., Centanin, L., Irisarri, M., Russo, D. M., Gleadle, J. M., Bocca, S. N., Muzzopappa, M., Ratcliffe, P. J., & Wappner, P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.19.6842-6853.2002 · Cited by 242
Self-citationHereditary paraganglioma targets diverse paraganglia: Table 1
Baysal, B. E. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.9.617 · Cited by 235
Kuznetsova, A. V., Meller, J., Schnell, P. O., Nash, J. A., Ignacak, M. L., Sanchez, Y., Conaway, J. W., Conaway, R. C., & Czyzyk-Krzeska, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0436037100 · Cited by 232
JmjC: cupin metalloenzyme-like domains in jumonji, hairless and phospholipase A2β
Clissold, P. M., & Ponting, C. P. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01700-x · Cited by 229
Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia
Sogawa, K., Numayama-Tsuruta, K., Ema, M., Abe, M., Abe, H., & Fujii-Kuriyama, Y. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7368 · Cited by 224 · cited 1×
“Nevertheless, other studies have shown that NO donors might reduce HIF transcriptional activity in hypoxi”
BackgroundMcNEILL, L. A., HEWITSON, K. S., CLARIDGE, T. D., SEIBEL, J. F., HORSFALL, L. E., & SCHOFIELD, C. J. (2002) · Biochemical Journal · doi:10.1042/bj20021162 · Cited by 215
Self-citationHIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O2 levels
Masson, N., & Ratcliffe, P. J. (2003) · Journal of Cell Science · doi:10.1242/jcs.00655 · Cited by 215
Self-citationSandau, K. B., Zhou, J., Kietzmann, T., & Brüne, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107689200 · Cited by 213
Involvement of Hypoxia-Inducible Factor 1 in Human Cancer.
SEMENZA, G. L. (2002) · Internal Medicine · doi:10.2169/internalmedicine.41.79 · Cited by 208
Fandrey, J., & Bunn, H. (1993) · Blood · doi:10.1182/blood.v81.3.617.617 · Cited by 205
del Peso, L., Castellanos, M. C., Temes, E., Martín-Puig, S., Cuevas, Y., Olmos, G., & Landázuri, M. O. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308862200 · Cited by 205
Dann, C. E., Bruick, R. K., & Deisenhofer, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202614999 · Cited by 200
Myllylä, R., Majamaa, K., Günzler, V, Hanauske-Abel, H. M., & Kivirikko, K. I. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91023-9 · Cited by 200
Characterization of the iron- and 2-oxoglutarate-binding sites of human prolyl 4-hydroxylase
Myllyharju, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.6.1173 · Cited by 200
Warnecke, C., Griethe, W., Weidemann, A., Jürgensen, J. S., Willam, C., Bachmann, S., Ivashchenko, Y., Wagner, I., Frei, U., Wiesener, M., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-1062fje · Cited by 200
Mammalian EGLN genes have distinct patterns of mRNA expression and regulation
Lieb, M. E., Menzies, K., Moschella, M. C., Ni, R., & Taubman, M. B. (2002) · Biochemistry and Cell Biology · doi:10.1139/o02-115 · Cited by 186 · cited 1×
“For example, PHD1 is particularly abundant in the testis, whereas PHD3 is strongly expressed in the hear”
BackgroundHIF‐1‐dependent transcriptional activity is required for oxygen‐mediated HIF‐1α degradation
Berra, E., Richard, D. E., Gothié, E., & Pouysségur, J. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02159-7 · Cited by 182
Zhang, Z., Ren, J., Harlos, K., McKinnon, C. H., Clifton, I. J., & Schofield, C. J. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02520-6 · Cited by 170
Self-citationLavaissière, L., Jia, S., Nishiyama, M., de la Monte, S. M., Stern, A. M., Wands, J. R., & Friedman, P. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118918 · Cited by 153
Zhou, J., Kelly, W. L., Bachmann, B. O., Gunsior, M., Townsend, C. A., & Solomon, E. I. (2001) · Journal of the American Chemical Society · doi:10.1021/ja004025+ · Cited by 151
Pavel, E. G., Zhou, J., Busby, R. W., Gunsior, M., Townsend, C. A., & Solomon, E. I. (1998) · Journal of the American Chemical Society · doi:10.1021/ja972408a · Cited by 147
Oxygen and Iron Regulation of Iron Regulatory Protein 2
Hanson, E. S., Rawlins, M. L., & Leibold, E. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302798200 · Cited by 146
2-Oxoglutarate analogue inhibitors of hif prolyl hydroxylase
Mole, D. R., Schlemminger, I., McNeill, L. A., Hewitson, K. S., Pugh, C. W., Ratcliffe, P. J., & Schofield, C. J. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00539-0 · Cited by 145
Self-citationOxygenases: mechanisms and structural motifs for O2 activation
Bugg, T. D. H. (2001) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00236-2 · Cited by 144
Jiang, Y., Zhang, W., Kondo, K., Klco, J. M., Martin, T. B. S., Dufault, M. R., Madden, S. F., Kaelin, W. G., & Nacht, M. (2003) · PubMed · Cited by 139
Lee, C., Kim, S. J., Jeong, D. G., Lee, S. M., & Ryu, S. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210385200 · Cited by 138
Gradin, K., Takasaki, C., Fujii‐Kuriyama, Y., & Sogawa, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201307200 · Cited by 128
Ryle, M. J., Liu, A., Muthukumaran, R. B., Ho, R. Y. N., Koehntop, K. D., McCracken, J., QUE, L. J., & Hausinger, R. P. (2003) · Biochemistry · doi:10.1021/bi026832m · Cited by 127
Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression)
Seth, P., Krop, I. E., PORTER, D. A., & Polyák, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205113 · Cited by 126
Kinetic and crystallographic studies on deacetoxycephalosporin C synthase (DAOCS)
Lee, H. J., Lloyd, M. D., Harlos, K., Clifton, I. J., Baldwin, J. E., & Schofield, C. J. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4649 · Cited by 110
Self-citationErez, N., Milyavsky, M., Eilam, R., Shats, I., Goldfinger, N., & Rotter, V. (2003) · PubMed · Cited by 106
Lipscomb, E. A., Sarmiere, P. D., & Freeman, R. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008407200 · Cited by 98
Crystal Structure of Carbapenem Synthase (CarC)
Clifton, I. J., Doan, L. X., Sleeman, M. C., Topf, M., Suzuki, H., Wilmouth, R. C., & Schofield, C. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213054200 · Cited by 97
Self-citationThe Selectivity and Inhibition of AlkB
Welford, R. W. D., Schlemminger, I., McNeill, L. A., Hewitson, K. S., & Schofield, C. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211058200 · Cited by 96
Self-citationJansen, G. A., Hogenhout, E. M., Ferdinandusse, S., Waterham, H. R., Ofman, R., Jakobs, C., Skjeldal, O. H., & Wanders, R. J. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.8.1195 · Cited by 87
Linke, S., Stojkoski, C., Kewley, R. J., Booker, G. W., Whitelaw, M. L., & Peet, D. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313614200 · Cited by 85
Identification of a novel growth factor-responsive gene in vascular smooth muscle cells
Wax, S. D., Rosenfield, C. L., & Taubman, M. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99981-3 · Cited by 82
Induction of cell growth regulatory genes by p53.
Madden, S. L., Galella, E. A., Riley, D., Bertelsen, A. H., & Beaudry, G. A. (1996) · PubMed · Cited by 80
Stapon, A., Li, R., & Townsend, C. A. (2003) · Journal of the American Chemical Society · doi:10.1021/ja034248a · Cited by 77
Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases
Schlemminger, I., Mole, D. R., McNeill, L. A., Dhanda, A., Hewitson, K. S., Tian, Y., Ratcliffe, P. J., Pugh, C. W., & Schofield, C. J. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00149-5 · Cited by 71
Self-citationWang, F., Sekine, H., Kikuchi, Y., Takasaki, C., Miura, C., Heiwa, O., Shuin, T., Fujii‐Kuriyama, Y., & Sogawa, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00729-5 · Cited by 70
Inactivation of 1-Aminocyclopropane-1-carboxylate Oxidase Involves Oxidative Modifications
Barlow, J. N., Zhang, Z., John, P., Baldwin, J. E., & Schofield, C. J. (1997) · Biochemistry · doi:10.1021/bi962521y · Cited by 58
Self-citationDann (2002) · Medical Entomology and Zoology · Cited by 58
Leu-574 of HIF-1α Is Essential for the von Hippel-Lindau (VHL)-mediated Degradation Pathway
Huang, E. L., Pete, E. A., Schau, M., Milligan, J., & Gu, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207280200 · Cited by 44
Alteration of the Co-substrate Selectivity of Deacetoxycephalosporin C Synthase
Lee, H., Lloyd, M. D., Clifton, I. J., Harlos, K., Dubus, A., Baldwin, J. E., Frère, J., & Schofield, C. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100085200 · Cited by 40
Self-citationWu, M., Moon, H., Begley, T. P., Myllyharju, J., & Kivirikko, K. I. (1999) · Journal of the American Chemical Society · doi:10.1021/ja981193h · Cited by 35
Martín-Puig, S., Temes, E., Olmos, G., Jones, D., Aragonés, J., & Landázuri, M. O. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310658200 · Cited by 12
Cited by
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
“HIF-1 is a heterodimeric transcription factor, consisting of HIF1a and HIF-1b subunits, which functions as a master regulator of oxygen homeostasis in all metazoan species (Schofield and Ratcliffe, 2004; Semenza, 2004).”
BackgroundOxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
“…Under well-oxygenated conditions HIFa becomes hydroxylated at one (or both) of two highly conserved prolyl residues located near the NTAD by members of the prolyl hydroxylase domain (PHD) family (also called EgIN family or HPH family) (for reviews see Kaelin, 2005; Schofield and Ratcliffe, 2004).”
BackgroundInfluentialSelf-citationSuccinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108
NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α
Rius, J., Guma, M., Schachtrup, C., Akassoglou, K., Zinkernagel, A. S., Nizet, V., Johnson, R. S., Haddad, G. G., & Karin, M. (2008) · Nature · doi:10.1038/nature06905 · Cited by 1,614
Metadata
- Authors
- Schofield, C. J., & Ratcliffe, P. J.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Ratcliffe, Peter J.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2004-05
- Volume
- 5
- Issue
- 5
- Pages
- 343-354
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1991346678
- Semantic Scholar
- 17237b87d7ea79ae6e18c24d4de83bfeffbd7c2e
- Cited by
- 2,068
- References
- 109
- Citations by year
- 2026: 62 · 2025: 55 · 2024: 92 · 2023: 90 · 2022: 121 · 2021: 95 · 2020: 106 · 2019: 80 · 2018: 95 · 2017: 91 · 2016: 106 · 2015: 99 · 2014: 120 · 2013: 83 · 2012: 76
- FWCI
- 6.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Commission
- Medical Research Council
- Biotechnology and Biological Sciences Research Council (B18672, BBS/B/07683)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- hypoxia-inducible factor, oxygen sensing, 2-oxoglutarate-dependent dioxygenase, oxygen homeostasis, transcriptional regulation, molecular oxygen
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Hydroxylation, Ketoglutaric Acids, Oxygen, Oxygenases, Transcription Factors, Cell Hypoxia, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.